by Elizabeth Kissling | Oct 27, 2009 | Law/Legal, Menopause, Pharmaceutical
Connie Barton, an Illinois woman who developed breast cancer after taking Prempro for menopausal symptoms, was awarded punitive damages by a jury in Philadelphia yesterday. The jury has already awarded her $3.7 million in compensatory damages, back in September, but...
by Chris Hitchcock | Oct 8, 2009 | Birth Control, New Research, Pharmaceutical
In a review article in the journal Trends in Ecology and Evolution, University of Sheffield researchers Alexandra Alvergne and Virpi Lummaa [1] present a range of evidence that using oral contraceptives influences women’s preferences for mates, and men’s sexual...
by Elizabeth Kissling | Oct 1, 2009 | Birth Control, Menstruation, Pharmaceutical
The Federal Drug Administration (FDA) announced today that Mirena® has been approved for use as treatment for heavy menstrual bleeding. Mirena® is an intra-uterine device (IUD) for preventing pregnancy. It combines the technology of old-school IUDs with the hormone...
by Elizabeth Kissling | Sep 26, 2009 | Law/Legal, Newspapers, Pharmaceutical
The popular birth control pill, Yaz is in the news again. Readers may remember that last autumn, Bayer (the maker of Yaz) was sanctioned by the FDA for their television commercials, “because they encourage use of Yaz in circumstances other than those in which...
by Elizabeth Kissling | Aug 5, 2009 | New Research, Pharmaceutical
I’m shocked! Shocked, I tell you. The New York Times reports today that Wyeth, makers of Premarin and Prempro, hired ghostwriters to develop medical journal articles that promoted the use of these hormone treatments. The articles emphasized the benefits and...
